Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Anti-inflammatory baricitinib is a life-saving COVID-19 drug

March 4, 2022 Medical Communications

UK experts say they have identified another life-saving drug that can alleviate COVID-19 illness. The anti-inflammatory baricitinib is usually used …
News

Risk of hospitalisation five times higher with J&J

March 3, 2022 Business Services, Medical Communications

A study published in Jama Network Open has revealed that Johnson & Johnson’s coronavirus vaccine was far less effective at …
News

FDA grants breakthrough therapy designation to RSV vaccine

March 3, 2022 Business Services, Medical Communications

The FDA has granted a Breakthrough Therapy Designation to Pfizer’s respiratory syncytial virus (RSV) vaccine candidate, for the prevention of …
News

WHO recommends Merck’s COVID-19 pill

March 3, 2022 Business Services, Medical Communications

WHO have recommended Merck’s pill, molnupiravir, for the treatment of COVID-19 in patients in high risk groups, such as the …
News

Study reveals potential genetic determinants of unexplained child deaths

February 25, 2022 Medical Communications

Various genetic determinants may cause a predisposition to Sudden Unexpected Death in Paediatrics (SUPD), which encompasses syndromes such as Sudden …
News
sydney-rae-jk6kt2jmy4w-unsplash

NICE draft guidance recommends tucatinib for advanced breast cancer

February 25, 2022 Medical Communications

Roughly 400 people with advanced breast cancer are set to benefit from a new treatment, following the NICE publication of …
News

CHMP recommends QUVIVIQ in Europe as a new treatment for adult insomnia patients

February 25, 2022 Medical Communications

The CHMP has adopted a positive opinion for the use of QUVIVIQ for the treatment of adult patients with insomnia. …
News

Plant-based COVID-19 vaccine approved

February 25, 2022 Medical Communications

Medicago and GlaxoSmithKline (GSK) have announced the approval by Health Canada of COVIFENZ®, a COVID-19 vaccine manufactured in plants, with …
News

Study shows antibiotics affect gut microbes of newborns

February 18, 2022 Medical Communications

Researchers from the Universities of Edinburgh and Birmingham, with the Spaarne Hospital and University Medical Centre Utrecht, Netherlands, have conducted …
News

Pfizer and BioNTech Omicron vaccine delayed

February 18, 2022 Medical Communications

The delivery of Pfizer and BioNTech SE’s vaccine, targeted specifically towards the Omicron COVID-19 variant has been delayed by several …
News

NHS bosses call for free COVID-19 tests and isolation to remain

February 18, 2022 Medical Communications

NHS bosses have called for free COVID-19 testing to remain, in spite of speculation that this could be scrapped. Boris …
News

Trial paused for respiratory virus vaccine in pregnant women

February 18, 2022 Medical Communications

GlaxoSmithKline (GSK) has hit pause on a Phase III clinical trial on safety grounds. The late-stage trial for GSK’s vaccine …
News

Astellas and Seagen announce results of study into muscle-invasive bladder cancer

February 15, 2022 Medical Communications

Astellas Pharma and Seagen announced the initial results from Cohort H of their EV-103 trial. This investigated PADDCEV (enfortumab vedotin-ejfv) …
News

NICE recommends new diagnostic devices for men with suspected prostate cancer

February 15, 2022 Medical Communications

NICE have recommended four new diagnostic devices for men with suspected prostate cancer, which reduce the chances of biopsy related …
News

Risk of new heart problems raised after COVID-19

February 11, 2022 Medical Communications

A large study has found that long after recovery from COVID-19, people continue to face significantly higher risks for new …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025